13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001527166
Total reported value
$10.0B
$10.0B
31 檔
8.4%
As reported in its official Q2 2024 Form 13F filing, Carlyle Group Inc.'s tracked investment portfolio stood at $10.0B with 31 total positions.
In Q2 2024, Carlyle Group Inc. adopted a defensive or profit-taking posture, trimming 3 positions and completely liquidating 3 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including QDEL, GTM, SLNOEUR) accounted for 8.4% of total reported equity market value during Q2 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | QDEL | Quidelortho CORP | Stock-Other | 36.35% | — | -7.54% | |
| 2 | GTM | Zoominfo Technologies Inc | Stock-Tech | 20.91% | — | -34.29% | |
| 3 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 15.80% | — | — | |
| 4 | GDS | Gds Holdings LTD - Adr | Stock-Other | 3.59% | — | — | |
| 5 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 3.40% | +0.01% | — | |
| 6 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 3.37% | — | — | |
| 7 | GETY | Getty Images Holdings Inc | Stock-Other | 2.85% | — | — | |
| 8 | ✓ | Hillevax Inc | Stock-Other | 2.51% | — | — | |
| 9 | JSPR | Jasper Therapeutics Inc | Stock-Other | 2.30% | -0.01% | — | |
| 10 | QTTB | Q32 Bio Inc | Stock-Other | 1.82% | -0.06% | — | |
| 11 | SMHI | Seacor Marine Holdings Inc | Stock-Other | 1.68% | — | — | |
| 12 | INVH | Invitation Homes Inc | Stock-Real Estate | 1.63% | +0.04% | — | |
| 13 | CUBE | Cubesmart | Stock-Real Estate | 0.95% | -0.08% | EXIT | |
| 14 | SPWR | Sunpower Inc | Stock-Other | 0.52% | +0.01% | — | |
| 15 | ✓ | Reneo Pharmaceuticals Inc | Stock-Other | 0.39% | — | — | |
| 16 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.39% | — | — | |
| 17 | DNUT | Krispy Kreme Inc | Stock-Other | 0.35% | — | — | |
| 18 | TORCEUR | Adicet Bio Inc | Stock-Other | 0.34% | — | — | |
| 19 | SPRU | Spruce Power Holding Corporation | Stock-Other | 0.14% | — | — | |
| 20 | AON | Aon plc | Stock-Financials | 0.14% | — | — | |
| 21 | NABL | N-able Inc | Stock-Other | 0.14% | — | — | |
| 22 | AVGO | Broadcom Inc | Stock-Tech | 0.12% | — | — | |
| 23 | 0OIA | Solarwinds CORP | Stock-Other | 0.11% | — | — | |
| 24 | NU | Nu Holdings Ltd. | Stock-Financials | 0.07% | — | -23.39% | |
| 25 | DASH | Doordash Inc - A | Stock-Consumer Disc | 0.04% | — | — | |
| 26 | ✓ | Nucana PLC | Stock-Other | 0.03% | — | — | |
| 27 | SYRE | Spyre Therapeutics Inc | Stock-Other | 0.02% | — | EXIT | |
| 28 | ✓ | Stock-Other | 0.01% | — | — | ||
| 29 | XCUREUR | Exicure Inc | Stock-Other | 0.01% | — | — | |
| 30 | EFTR | Effector Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 31 | MTEMEUR | Molecular Templates Inc | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SLNOEUR | Soleno Therapeutics Inc | +4.9% | — | Unchanged |
| 2 | GDS | Gds Holdings LTD - Adr | +1.9% | — | Unchanged |
| 3 | PHAT | Phathom Pharmaceuticals Inc | +1.1% | — | Unchanged |
| 4 | VRNA | Verona Pharma PLC - Adr | +0.9% | — | Unchanged |
| 5 | QTTB | Q32 Bio Inc | +0.7% | — | Unchanged |
| 6 | ✓ | Hillevax Inc | +0.6% | — | Unchanged |
| 7 | INVH | Invitation Homes Inc | +0.6% | — | Unchanged |
| 8 | SMHI | Seacor Marine Holdings Inc | +0.5% | — | Unchanged |
| 9 | GETY | Getty Images Holdings Inc | +0.4% | — | Unchanged |
| 10 | SPWR | Sunpower Inc | +0.4% | — | Unchanged |
| 11 | JSPR | Jasper Therapeutics Inc | +0.3% | — | Unchanged |
| 12 | CUBE | Cubesmart | +0.3% | — | Unchanged |
| 13 | EM | Smart Share Global LTD - Adr | +0.2% | — | Unchanged |
| 14 | AON | Aon plc | +0.1% | NEW | New buy |
| 15 | ✓ | Reneo Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 16 | AVGO | Broadcom Inc | +0.1% | — | Unchanged |
| 17 | NABL | N-able Inc | +0.1% | — | Unchanged |
| 18 | 0OIA | Solarwinds CORP | 0% | — | Unchanged |
| 19 | ✓ | Nucana PLC | 0% | NEW | New buy |
| 20 | DNUT | Krispy Kreme Inc | 0% | — | Unchanged |
| 21 | NU | Nu Holdings Ltd. | 0% | -23.39% | Trim |
| 22 | SPRU | Spruce Power Holding Corporation | — | — | Unchanged |
| 23 | SYRE | Spyre Therapeutics Inc | — | — | Unchanged |
| 24 | DASH | Doordash Inc - A | — | — | Unchanged |
| 25 | XCUREUR | Exicure Inc | — | — | Unchanged |
| 26 | MTEMEUR | Molecular Templates Inc | — | — | Unchanged |
| 27 | 8QR | Confluent Inc-class A | 0% | EXIT | Sold out |
| 28 | ✓ | 0% | — | Unchanged | |
| 29 | ✓ | Nucana PLC Sponsored Adr | -0.1% | EXIT | Sold out |
| 30 | TORCEUR | Adicet Bio Inc | -0.1% | — | Unchanged |
| 31 | EFTR | Effector Therapeutics Inc | -0.2% | — | Unchanged |
| 32 | QDEL | Quidelortho CORP | -1.3% | -7.54% | Trim |
| 33 | GTM | Zoominfo Technologies Inc | -5.6% | -34.29% | Trim |
| 34 | ✓ | Vitru LTD | -5.9% | EXIT | Sold out |
According to official SEC Form 13F filings, Carlyle Group Inc. reported a total U.S. public equity portfolio value of $10.0B across 31 disclosed positions in Q2 2024.
During Q2 2024, Carlyle Group Inc.'s top holdings by market value included QDEL (36.4%)、GTM (20.9%)、SLNOEUR (15.8%). The largest single position, QDEL, represented 36.4% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
AON
市值: $1.5M
Top Position Liquidated / Trimmed
VITRU LTD
前期市值: $94.0M
In Q2 2024, Carlyle Group Inc. made 8 total portfolio adjustments, initiating 2 new buys, adding to 0 positions, trimming 3 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.